Member Info for Andyagogo

GSK continue to pay out an uncovered dividend while carrying a large amount of debt. It can't continue. And it is costing shareholders dearly in terms of share price underperformance. A lower payout that was viewed as sustainable would result in a higher share price, not a lower one.

Not the case. Read the RNS. They are granted those shares as part of a renumeration package. Certainly not my definition of a director share purchase. It's a purchase when you have to Pay with your own money for shares imv.

GSK continues to trade on the NYSE after the LSE closes. GSK ADR.

Those read very well!!. Any thoughts ?.

I added yesterday on the dip, 627.38 my lowest buy, just missed another under 627. Intend to add lower, if available. My view is a longer term , so short term technicals not a consideration. Usually try to add when longer term risk/reward look reasonable. Nearly a decade in to a bull market not much that looks a bargain, and would not label Tate as such. Reasonable longer term value hopefully. Very much a case of DYOR, as always.

I'm afraid it can really. Firstly take in to account we are at record stock market levels, 8 years in to a bull market, what happens during the next severe stock market fall?. Then consider the wider economic context, this is as good as it gets for the UK economy imv. Generational low unemployment, nearly a decade in to an economic expansion. Will Marstons feel no impact as the current economic cycle turns down in to the next recession?. You can make a case the very significant share price fall discounts some of this, but all?. Very much doubt it, just IMV Only, as always DYOR. My best guess on wider macro is the UK will be in recession within 12 months, if not it will be very close.

Will keep MARS on a watchlist, good luck to anyone holding.

Eludes even - that's a case in point!.

Appreciate your view. I had some JDW at floatation, I was 19 at the time. Sold shortly afterwards for about a �70 profit thinking I was genius, I wasn't !. Dread to think what they would be worth now. Genius still elludes me for some reason ). Best Regards.

Well as my GSK dividend was paid today and it put a smile on my face, I like income. However even in the case of GSK, the dividend should be lower, its significantly too high in the context of FCF and GSK net debt. If dividend sustainability is questioned by the market there is a price to pay for that fat yeild, and the price paid will be seen in SP underperformance Over the last 1,3,5,10 years, would you have been better in JDW with a held dividend(can't remember the last time jdw raised the payout) or in holding MARS. That's what an investor interested in longer term timeframes should be asking. All IMV only.

Traded MARS twice recently. My last trade was buying just before the close Monday, sold those Tuesday. So no current position, and I do not go short individual stocks. My view?, Is that outlined earlier. I like the Company An aggressive cutting in expansionary CAPEX and a possible rebasing of the dividend lower leaves MARS more interesting IMV The SA article was interesting and it made similar points to those I raised sometime ago.

When I first mentioned cutting 2018/19 CAPEX many disagreed. But here's the thing folks.. if the market loved MARS current strategy the share price would not have been hammered over the last few months. Ah but I can hear some say.. it's Marco concerns, Brexit uncertainty etc, and yes I agree, however that is only half the story. The JDW share price is at near record highs with the same economic background. To see just how stark the picture is, compare MARS and JDW over 12 months, 3 years etc. The market is focussed on free cash flow/debt as we are likely late in the cycle. So unless MARS really take an axe to CAPEX, focus on improving debt metrics, this negative sentiment will continue to hang heavy over the share price. This is all In My View Only, please DYOR as always.

Any of their directors buying?... Even following the savage share price fall. MARS CEO bought 3 separate lots as discussed in here.

Statement looks good IMV, any thoughts?.

No/m

It's an excellent article and concur with the author's view. You see here is the problem, we are at or close to peak cycle, the lowest unemployment in decades, and yet companies expand based on expexted metrics that may be blown out of the water on the next downturn. Cut CAPEX and trim the dividend, by 20% as a minimum.

May be an interesting buy point?. Any thoughts...

Thank you are clarifying that yesterday.

Big day in prospect. Let's see if KGF continue to maintain FY guidance. What I don't like is the relative lack of recent BOD buying with the share price near these levels.

On July 11, 2008 the share price hit 91.80 pence. Whether this was an intra-day on closing day low I'm unaware. So yes under £1. However cannot confirm that was an all time low.